Human tetanus immunoglobulin(Xinjiang Deyuan)

破伤风人免疫球蛋白(新疆德源)

Report date: 2023/02/08 10:13:22

Base Information

Drug NameHuman tetanus immunoglobulin(Xinjiang Deyuan)
Drug Alias NameN/A
ClassificationBiologics > Blood componentsBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTetanus
Global Approved IndicationsTetanus
Approved Indications in ChinaTetanus
Original Approved Country/TerritoryMainland China
Original Approved Date2023/01/29
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesXinjiang Deyuan Biological Engineering Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXinjiang Deyuan Biological Engineering Co Ltd
Inactive CompaniesN/A
Active IndicationsTetanus
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A